challenges in using car-t therapy & btk inhibitors in patients with r/r mcl
Published 1 year ago • 181 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:44
challenges in developing car-t therapy for aml
-
4:22
current challenges in car-t cell therapy and the role of the tumor microenvironment
-
1:38
challenges of car-t therapy in the real-world setting
-
1:27
challenges in car-t therapy for myeloid malignancies
-
1:46
exploring the use of btk inhibitors as a strategy to increase the efficacy of car-t cells
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
4:22
carcik trial updates: using sb-engineered car-t cells in patients with b-all
-
3:40
challenges that car-t therapy can present to patients
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
25:18
addressing the major challenges to car-t therapy in aml
-
0:56
key challenges in developing car-t therapy for cll
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
3:02
the challenges of using car-t cell therapy to treat patients with cll
-
2:08
challenges with car-t therapy in aml & insights into if-better-gated car-t cells
-
1:33
patient selection for car-t in all
-
6:22
current challenges faced with car t-cell therapies
-
3:17
challenges and next steps for car-t in b-cell lymphomas
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
2:17
the challenges of implementing car-t therapy in cll